Axsome Therapeutics, Inc (AXSM) insider trading

{
  "status": "OK",
  "results": [
    {
      "tickers": [
        "AXSM"
      ],
      "issuer_cik": "0001579428",
      "owner_cik": "0001805812",
      "accession_number": "0001193125-26-382277",
      "form_type": "4",
      "filing_date": "2026-09-03",
      "period_of_report": "2026-09-03",
      "issuer_name": "Axsome Therapeutics, Inc.",
      "issuer_trading_symbol": "AXSM",
      "owner_name": "Jacobson Mark L.",
      "is_director": false,
      "is_officer": true,
      "is_ten_percent_owner": false,
      "is_other": false,
      "officer_title": "Chief Operating Officer",
      "security_type": "non_derivative",
      "record_type": "transaction",
      "security_title": "Common Stock",
      "transaction_timeliness": "O",
      "aff_10b5_one": true,
      "transaction_date": "2026-09-03",
      "transaction_code": "S",
      "equity_swap_involved": false,
      "transaction_shares": 10000,
      "transaction_price_per_share": 208.65,
      "transaction_acquired_disposed": "D",
      "shares_owned_following_transaction": 0,
      "transaction_value": 2086500,
      "direct_or_indirect": "D",
      "footnotes": [
        {
          "id": "F2",
          "description": "Such transaction was pursuant to a pre-approved 10b5-1 plan."
        },
        {
          "id": "F3",
          "description": "Represents the subsequent sale of the underlying shares of the aforementioned exercise of stock options."
        },
        {
          "id": "F4",
          "description": "Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $206.41 and $210.34."
        }
      ]
    },
    {
      "tickers": [
        "AXSM"
      ],
      "issuer_cik": "0001579428",
      "owner_cik": "0001219927",
      "accession_number": "0001193125-26-340688",
      "form_type": "4",
      "filing_date": "2026-08-07",
      "period_of_report": "2026-08-05",
      "issuer_name": "Axsome Therapeutics, Inc.",
      "issuer_trading_symbol": "AXSM",
      "owner_name": "TABUTEAU HERRIOT",
      "is_director": true,
      "is_officer": true,
      "is_ten_percent_owner": true,
      "is_other": false,
      "officer_title": "Chief Executive Officer",
      "security_type": "non_derivative",
      "record_type": "transaction",
      "security_title": "Common Stock",
      "transaction_timeliness": "O",
      "aff_10b5_one": true,
      "transaction_date": "2026-08-06",
      "transaction_code": "S",
      "equity_swap_involved": false,
      "transaction_shares": 4660,
      "transaction_price_per_share": 213.95,
      "transaction_acquired_disposed": "D",
      "shares_owned_following_transaction": 7229,
      "transaction_value": 997007,
      "direct_or_indirect": "D",
      "footnotes": [
        {
          "id": "F2",
          "description": "Such transaction was pursuant to a pre-approved 10b5-1 plan, which has now been completed."
        },
        {
          "id": "F3",
          "description": "Represents the subsequent sale of the underlying shares of the aforementioned exercise of stock options."
        },
        {
          "id": "F5",
          "description": "Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $212.41 and $216.36."
        }
      ]
    }
  ]
}

// trimmed to 2 results

The response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.